# FDA 483 - Lily C. Chao, M.D. - September 25, 2025

Source: https://www.globalkeysolutions.net/records/483/lily-c-chao-md/05ba6742-7bd7-4bc5-89fd-af45a43d59e4

> FDA 483 for Lily C. Chao, M.D. on September 25, 2025. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Lily C. Chao, M.D.
- Inspection Date: 2025-09-25
- Product Type: drugs
- Office Name: Los Angeles District Office
- Summary: The FDA issued a Form 483 to Lily C. Chao, M.D., a clinical investigator in Los Angeles, CA, following an inspection. Observations included failures to conduct an investigation in accordance with the investigational plan, specifically regarding updated informed consent and documented physician reviews. Additionally, the firm failed to maintain adequate and accurate case histories by not reporting adverse events and concomitant medications to the Sponsor.

## Related Officers

- [Veronica L. Bush](https://www.globalkeysolutions.net/people/veronica-l-bush/3582dd62-2cdf-4d1d-a78b-305c908ef9d5)

Company: https://www.globalkeysolutions.net/companies/lily-c-chao-md/ce04559f-4b2d-424d-92c2-20690a452401

Office: https://www.globalkeysolutions.net/offices/los-angeles-district-office/edcf1dfe-596a-43b8-8df4-07d9cd94763b